Skip to search formSkip to main contentSkip to account menu

SC 58125

Known as: SC-58125, SC58125 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Running title : Spinal COX-2 , aldose reductase and pain
Hyperalgesia to noxious stimuli is accompanied by increased spinal cyclooxygenase-2 (COX-2) protein in diabetic rats. The present… 
2006
2006
A COX-2 inhibitor, SC58125, promotes liver carcinogenesis in a rat medium-term liver bioassay, possibly due to induction of CYP 2B1 and 3A1
2005
2005
Inhibitory Effects of Celecoxib and Sc-58125 on Proliferation of Human Carcinoma of Larynx Hep-2 In Vitro
The inhibitory effects of two kinds of selective cyclooxygenase-2 inhibitors on the proliferation of human carcinoma of larynx… 
2005
2005
SC58125 modulates TNF-α-induced HT-29 cells apoptosis through inhibiting IκBα degradation
Aim To investigate whether SC58125 synergized with TNF-α to induce HT-29 cell apoptosis and study the possible molecular… 
2005
2005
The biology and regulation of activating transcription factor 3 (ATF3) by nonsteroidal anti-inflammatory drugs (NSAIDs) and dietary compounds with chemopreventive activity.
Bottone, Jr., Frank Gerard. THE BIOLOGY AND REGULATION OF ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3) BY NONSTEROIDAL… 
2002
2002
Effect of SC58125 on cell proliferation and apoptosis in HepG-2 cells
AIM: To clarify the effect of SC58125 on cell proliferation and apoptosis in HepG-2 cells and explore the molecular mechanisms… 
1998
1998
Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends On
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)